Literature DB >> 24357102

Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study.

Thanh G N Ton1, Mary Lou Biggs, Diane Comer, Lesley Curtis, Shu-Ching Hu, Evan L Thacker, Susan Searles Nielsen, Joseph A Delaney, Douglas Landsittel, William T Longstreth, Harvey Checkoway, Samay Jain.   

Abstract

PURPOSE: We sought to improve a previous algorithm to ascertain Parkinson's disease (PD) in the Cardiovascular Health Study by incorporating additional data from Medicare outpatient claims. We compared our results to the previous algorithm in terms of baseline prevalence and incidence of PD, as well as associations with baseline smoking characteristics.
METHODS: Our original case ascertainment used self-reported diagnosis, antiparkinsonian medication, and hospitalization discharge International Classification of Diseases-Ninth version code. In this study, we incorporated additional data from fee-for-service Medicare claims, extended follow-up time, review of hospitalization records, and adjudicated cause of death. Two movement disorders specialists adjudicated final PD status. We used logistic regression models and controlled for age, sex, African American race, and education.
RESULTS: We identified 75 additional cases but reclassified 80 previously identified cases as not having PD. We observed significant inverse association with smoking status (odds ratio = 0.42; 95% confidence interval (CI) = 0.22, 0.79), and inverse linear trends with pack-years (p = 0.005), and cigarettes per day (p = 0.019) with incident PD. All estimates were stronger than those from the previous algorithm.
CONCLUSIONS: Our enhanced method did not alter prevalence and incidence estimates compared with our previous algorithm. However, our enhanced method provided stronger estimates of association, potentially due to reduced level of disease misclassification.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ICD-9; Parkinson's disease; cardiovascular disease; cardiovascular health study; epidemiology; medical records; pharmacoepidemiology

Mesh:

Substances:

Year:  2013        PMID: 24357102      PMCID: PMC3923620          DOI: 10.1002/pds.3552

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  28 in total

1.  A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.

Authors:  Miguel A Hernán; Bahi Takkouche; Francisco Caamaño-Isorna; Juan J Gestal-Otero
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

2.  Tobacco consumption and mortality from cancer and other diseases.

Authors:  H F DORN
Journal:  Public Health Rep       Date:  1959-07       Impact factor: 2.792

3.  Caffeine, postmenopausal estrogen, and risk of Parkinson's disease.

Authors:  A Ascherio; H Chen; M A Schwarzschild; S M Zhang; G A Colditz; F E Speizer
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

4.  Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity.

Authors:  Stephen K Van Den Eeden; Caroline M Tanner; Allan L Bernstein; Robin D Fross; Amethyst Leimpeter; Daniel A Bloch; Lorene M Nelson
Journal:  Am J Epidemiol       Date:  2003-06-01       Impact factor: 4.897

5.  Alcohol consumption and the incidence of Parkinson's disease.

Authors:  Miguel A Hernán; Honglei Chen; Michael A Schwarzschild; Alberto Ascherio
Journal:  Ann Neurol       Date:  2003-08       Impact factor: 10.422

Review 6.  Systematic review of incidence studies of Parkinson's disease.

Authors:  Dominique Twelves; Kate S M Perkins; Carl Counsell
Journal:  Mov Disord       Date:  2003-01       Impact factor: 10.338

7.  Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

Authors:  Honglei Chen; Shumin M Zhang; Miguel A Hernán; Michael A Schwarzschild; Walter C Willett; Graham A Colditz; Frank E Speizer; Alberto Ascherio
Journal:  Arch Neurol       Date:  2003-08

8.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

9.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

10.  Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk.

Authors:  S M Zhang; M A Hernán; H Chen; D Spiegelman; W C Willett; A Ascherio
Journal:  Neurology       Date:  2002-10-22       Impact factor: 9.910

View more
  4 in total

1.  Validation of secondary data sources to identify Parkinson disease against clinical diagnostic criteria.

Authors:  Samay Jain; Jayandra Himali; Alexa Beiser; Thanh G N Ton; Margaret Kelly-Hayes; Mary Lou Biggs; Joseph A C Delaney; Caterina Rosano; Sudha Seshadri; Samuel A Frank
Journal:  Am J Epidemiol       Date:  2014-12-29       Impact factor: 4.897

2.  Predictors of incident epilepsy in older adults: The Cardiovascular Health Study.

Authors:  Hyunmi Choi; Alison Pack; Mitchell S V Elkind; W T Longstreth; Thanh G N Ton; Frankline Onchiri
Journal:  Neurology       Date:  2017-01-27       Impact factor: 9.910

3.  Parkinson's disease case ascertainment in prospective cohort studies through combining multiple health information resources.

Authors:  Marije Reedijk; Anke Huss; Robert A Verheij; Petra H Peeters; Roel C H Vermeulen
Journal:  PLoS One       Date:  2020-07-01       Impact factor: 3.240

4.  Completeness of cohort-linked U.S. Medicare data: An example from the Agricultural Health Study (1999-2016).

Authors:  Christine G Parks; Srishti Shrestha; Stuart Long; Thomas Flottemesch; Sarah Woodruff; Honglei Chen; Gabriella Andreotti; Jonathan N Hofmann; Laura E Beane Freeman; Dale P Sandler
Journal:  Prev Med Rep       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.